true

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology

Connect to confidence, care and comfort

Overview
Specifications
Products & Accessories
EIFU & Resources
FAQ

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology elevates the level of safety by combining needlestick safety with blood control technology compared to a non-safety, non-blood control catheter.

true

Approximately 90% of hospital patients receive IV therapy.¹ Globally, 1 billion+ peripheral IV catheters are placed every year.²

95% of IV catheters placed are PIVCs.¹ Based on clinical studies, risks associated with PIVC use include:

Potentially high frequency of PIV catheter complications

35–50% of hospitalized patients who receive a PIVC experience a catheter-related complication.³

Occurance of blood exposure

In a study, when clinicians used a PIVC without blood control technology, blood leakage occurred 61% of the time,⁴ risking potential exposure to bloodborne pathogens (BBP).

Multiple PIVC insertion attempts

An emergency department study suggests that first attempt insertion success ranges from 18–79%.⁶

Multiple insertion attempts increase the risk to clinicians of needlestick injury (NSI) and potential exposure to BBP, and undue pain and increased infection risk to the patient.⁶

When clinician safety and patient comfort and care are critical, BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology**:

Eliminates the need for venous compression

during insertion, connections and disconnections, and blood draws, reducing the risk of blood exposure.^**,7

during insertion, connections and disconnections, and blood draws, reducing the risk of blood exposure.^**,7
Reduces blood exposure risk**

by stopping blood flow during conections and reconnections.^{^,7}
Provides immediate visual confirmation

of vessel entry with BD Instaflash™ Needle Technology, improving opportunities for first attempt insertion success.^*,8,9
Provides protection from needlestick injuries (NSIs)

with integrated passive safety system.
Offers an ergonomic design

that is easily adaptable to preferred insertion techniqes and provides enhanced control throughout the procedure.
Clinically demonstrated to reduce phlebitis

by up to 69% with BD Vialon™ Catheter Material,compared to an FEP catheter material.^10-12
Supports longer IV dwell times,

with BD Vialon™ Catheter Material.^††,13
Smooth, tapered catheter tip design

with smooth, tapered catheter tip design.^**

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology

The BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology is designed to enhance the confidence, care and comfort of clinicians and patients.

Without wings product no.	With wings product no.	Size	Inner diameter	Outer diameter	Gravity flow rate	Maximum power injector flow rate for constrast media viscoslty <=11.8 cP(mPa⋅s)	Maximum power injector flow rate for constrast media viscoslty <=27.5 cP(mPa⋅s)
BD Cathena^™ Safety IV Catheter with BD Multiguard™ Technology
386860	386880	24 G x .075 in  0.7x19 mm	0.53 mm	0.71 mm	20 mL/min 1,200 mL/hr	3.5 mL/sec	2.5 mL/sec
386861	386881	22 G x 1.00 in  0.9 x 25 mm	0.67 mm	0.90 mm	36 mL/min  (2,160 mL/hr)	6.0 mL/sec	3.5 mL/sec
-	386882	22 G x 2.00 in  0.9 x 51 mm	0.67 mm	0.90 mm	29 mL/min  (1,740 mL/hr)	6.0 mL/sec	3.5 mL/sec
386862	386883	20 G x 1.00 in  1.1 x 25 mm	0.83 mm	1.10 mm	64 mL/min  (3,840 mL/hr)	11.0 mL/sec	7.0 mL/sec
386863	386884	20 G x 1.25 in  1.1 x 32 mm	0.83 mm	1.10 mm	60 mL/min  (3,600 mL/hr)	11.0 mL/sec	7.0 mL/sec
368864	386885	20 G x 2.00 in  1.1 x 51 mm	0.83 mm	1.10 mm	52 mL/min  (3,120 mL/hr)	11.0 mL/sec	7.0 mL/sec
386865	386886	18 G x 1.25 in  1.3 x 32 mm	0.98 mm	1.31 mm	94 mL/min  (5,640 mL/hr)	16.0 mL/sec	10.0 mL/sec
386866	386887	18 G x 2.00 in  1.3 x 51 mm	0.98 mm	1.31 mm	87 mL/min  (5,220 mL/hr)	16.0 mL/sec	10.0 mL/sec
386867	386888	16 G x 1.25 in  1.7 x 32 mm	1.36 mm	1.74 mm	190 mL/min  (11,400 mL/hr)	27.0 mL/sec	18.0 mL/sec
386868	386889	16 G x 2.00 in  1.7 x 51 mm	1.36 mm	1.74 mm	176 mL/min  (10,560 mL/hr)	27.0 mL/sec	18.0 mL/sec
BD Cathena™ Safety IV Catheter without BD Multiguard™ Technology
386859	386879	24 G x 0.75 in 0.7 x 19 mm	0.53 mm	0.71 mm	20 mL/min  (1,200 mL/hr)	3.5 mL/sec	2.5 mL/sec
386871	386892	22 G x 1.00 in  0.9 x 25 mm	0.67 mm	0.90 mm	37 mL/min  (2,220 mL/hr)	6.0 mL/sec	3.5 mL/sec
-	386893	22 G x 2.00 in  0.9 x 51 mm	0.67 mm	0.90 mm	29 mL/min  (1,740 mL/hr)	6.0 mL/sec	3.5 mL/sec
386872	386894	20 G x 1.00 in  1.1 x 25 mm	0.83 mm	1.10 mm	65 mL/min  (3,900 mL/hr)	11.0 mL/sec	7.0 mL/sec
386873	386895	20 G x 1.25 in  1.1 x 32 mm	0.83 mm	1.10 mm	62 mL/min  (3,720 mL/hr)	11.0 mL/sec	7.0 mL/sec
386874	386896	20 G x 2.00 in  1.1 x 51 mm	0.83 mm	1.10 mm	52 mL/min  (3,120 mL/hr)	11.0 mL/sec	7.0 mL/sec
386875	386897	18 G x 1.25 in  1.3 x 32 mm	0.98 mm	1.31 mm	104 mL/min  (6,240 mL/hr)	16.0 mL/sec	10.0 mL/sec
386876	386898	18 G x 2.00 in  1.3 x 51 mm	0.98 mm	1.31 mm	90 mL/min  (5,400 mL/hr)	16.0 mL/sec	10.0 mL/sec
386869	386890	16 G x 1.25 in  1.7 x 32 mm	1.36 mm	1.74 mm	212 mL/min  (12,720 mL/hr)	27.0 mL/sec	18.0 mL/sec
386870	386891	16 G x 2.00 in  1.7 x 51 mm	1.36 mm	1.74 mm	200 mL/min  (12,000 mL/hr)	27.0 mL/sec	18.0 mL/sec

true

BD Cathena™ Safety IV Catheters are suitable for use with the power injectors set to a maximum pressure of 325 psi (2240 kPa).
Without wings catheters: 50 per shelf box, 200 per case
With wings catheters: 30 per shelf box, 120 per case
BD Cathena™ Safety IV Catheters are MR Conditional.
Please consult product labels and inserts for instructions for use, indications, contraindications, warnings, and precautions.

RELATED PRODUCTS NOT AVAILABLE

false

true

BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.

Learn more

BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.

Learn more

BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.

Learn more

BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.

Learn more

true

false

true

Disclaimers:

^*Compared to a non-notched needle^†Compared to an FEP catheter^{^}For up to 10 seconds^**Compared to a non-safety, non-blood control catheter
^††Compared to PTFE catheter material

iData Research Inc. Global Market Report Suite for Vascular Access Devices and Accessories. 2020.
Alexandrou E, Ray-Barruel G, Carr PJ, et al. International prevalence of the use of peripheral intravenous catheters. Journal of Hospital Medicine. 2015 Aug 1;10(8):530-533.
Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurse. 2015;38(3):189-203.
Haeseler G, Hildebrand M, Fritscher J. Efficacy and ease of use of an intravenous catheter designed to prevent blood leakage: prospective observational study. J Vasc Access. 2015;16(3):233-236.
Rickard C, Webster J, Wallis MC, et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet [serial online]. 2012;380:1066-1074.
Carr P, Rippey J, Budgeon C, Cooke M, Higgins N, Rickard C. Insertion of peripheral intravenous cannulae in the Emergency Department: factors associated with first-time insertion success. J Vasc Access. 2016;17(2):182-190.
Onia R, Eshu-Wilson I, Arce, C, et al. Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. CMRO. 2011;27(7):1339-1346. 8 Maki DG, Ringer M. Risk factors for infusionrelated phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
van Loon FHJ, Timmerman R, den Brok GPH, Korsten EHM, Dierick-van Daele ATM, Bouwman ARA. The impact of a notched peripheral intravenous catheter on the first attempt success rate in hospitalized adults: block-randomized trial. JVA. 2021 DOI: 10.1177/1129729821990217.
Seetharam AM, Raju U, Suresh K. A randomized controlled study to compare first stick success with Instaflash technology: The FIRSST study. JVA. 2022 DOI:10.1177/11297298221080369.
Kus B, Buyukyilmaz F. Effectiveness of Vialon biomaterial versus Teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020;e12328. https://doi.org/10.1111/jjns.12328
Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesthesia and Intensive Care. 1988;16:265-271.
Chhugani M, James M, Thokchom S. A randomized controlled trial to assess the effectiveness of Vialon™ cannula versus polytetrafluoroethylene (PTFE) cannula in terms of indwelling time and complications in patients requiring peripheral intravenous cannulation. International Journal of Science and Research. 2015;4(12).
Richardson D, Kaufman L. Reducing blood exposure risks and costs associated with SPIVC insertion. Nurse Manage. 2011;42(12):31-34.

BD-42420 (05/23)

true

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology

Approximately 90% of hospital patients receive IV therapy.1 Globally, 1 billion+ peripheral IV catheters are placed every year.2

95% of IV catheters placed are PIVCs.1 Based on clinical studies, risks associated with PIVC use include:

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology

あなたは医療関係者または研究者ですか

BD（Japan コーポレートサイト）から移動します

Approximately 90% of hospital patients receive IV therapy.¹ Globally, 1 billion+ peripheral IV catheters are placed every year.²

95% of IV catheters placed are PIVCs.¹ Based on clinical studies, risks associated with PIVC use include: